Stockscreener 앱 받기
2.37
2.47%
-0.06
Clearmind Medicine Inc 주식(CMND)의 최신 뉴스
Why Clearmind Medicine Inc. stock remains on buy listsTrail vs Road Selection & compare fit, width, and feel - ulpravda.ru
Will Clearmind Medicine Inc. stock deliver shareholder value2025 Breakouts & Breakdowns & Weekly Top Gainers Alerts - ulpravda.ru
Published on: 2026-01-09 01:57:04 - ulpravda.ru
Does Clearmind Medicine Inc. (CWY0) stock trade below intrinsic valueQuarterly Investment Review & Scalable Portfolio Growth Methods - ulpravda.ru
Will Clearmind Medicine Inc. stock benefit from AI adoptionStock Buy Signals & Target Triple-Digit Stock Opportunities - ulpravda.ru
Surprises Report: Why Clearmind Medicine Inc stock is recommended by analystsChart Signals & Safe Swing Trade Setups - moha.gov.vn
How geopolitical tensions affect Clearmind Medicine Inc. stock2026 world cup usa national team group stage defensive leaders possession football match prediction insights - ulpravda.ru
Why retail traders accumulate Clearmind Medicine Inc. (CWY0) stockStop Loss Placement Tips & Build Wealth With Zero-Cost Tools - bollywoodhelpline.com
Portfolio Shifts: Why Clearmind Medicine Inc stock is recommended by analystsRate Cut & Reliable Price Action Trade Plans - moha.gov.vn
Clearmind Medicine (CMND) Stock Analysis Report | Financials & Insights - Benzinga España
Clearmind Medicine Announces the Notice of an International Patent App... - Moscow-Pullman Daily News
Clearmind Medicine regains compliance with NASDAQ minimum bid price rule - MSN
Clearmind regains Nasdaq compliance as shares maintain $1 minimum - Investing.com India
Clearmind Medicine Says Nasdaq Compliance Regained on Minimum Bid Price Rule - MarketScreener
Clearmind Medicine regains compliance with Nasdaq minimum bid price rule - TipRanks
Clearmind regains Nasdaq compliance as shares maintain $1 minimum By Investing.com - Investing.com South Africa
Clearmind Medicine Inc. Regains Compliance with Nasdaq Listing Requirements - Quiver Quantitative
Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement - marketscreener.com
Clearmind Medicine highlights key 2025 achievements - MSN
Clearmind advances AUD treatment as phase I/IIa trial progresses By Investing.com - Investing.com Nigeria
Clearmind advances AUD treatment as phase I/IIa trial progresses - Investing.com
Clearmind Medicine Inc. Reflects on Major Progress in 2025 Clinical Trials for CMND-100 Targeting Alcohol Use Disorder - Quiver Quantitative
Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth - Yahoo Finance
Psychedelic: Clearmind completes second cohort enrollment for CMND-100 trial - MSN
Cash from operating activities of Clearmind Medicine Inc. – MUN:CWY - TradingView — Track All Markets
Trading Recap: How strong is Clearmind Medicine Inc. stock balance sheetJuly 2025 Selloffs & Weekly Setup with ROI Potential - moha.gov.vn
How interest rate cuts could boost Clearmind Medicine Inc. stock2025 Geopolitical Influence & Short-Term High Return Ideas - Улправда
Clearmind Medicine Inc. (NASDAQ: CMND)Share Price - intelligentinvestor.com.au
Published on: 2025-12-19 05:54:25 - Улправда
Pretax income of Clearmind Medicine Inc. – LS:A41YK5 - TradingView — Track All Markets
Clearmind Medicine completes second cohort enrollment in Phase I/IIa AUD trial - MSN
Free float of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Cash from financing activities of Clearmind Medicine Inc. – FWB:CWY - TradingView — Track All Markets
Cost of goods sold of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Gross profit of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
EBIT of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
EBIT per share of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Long term debt to total assets ratio of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Basic earnings per share (basic EPS) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Non-operating income (total) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Operating expenses (excl. COGS) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Clearmind Medicine Inc. Balance Sheet – LSX:A41YK5 - TradingView — Track All Markets
Price to cash flow ratio of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Diluted net income available to common stockholders of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Operating cash flow per share of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
CapEx per share of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Enterprise value to EBITDA ratio of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Operating margin % of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Total revenue of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Published on: 2025-12-18 16:01:28 - Улправда
Clearmind Medicine Inc. Cash Flow – LSX:A41YK5 - TradingView — Track All Markets
Clearmind Medicine Inc. Earnings and Revenue – LSX:A41YK5 - TradingView — Track All Markets
Is Clearmind Medicine Inc. stock a top momentum playJuly 2025 Summary & Community Verified Trade Signals - Улправда
Price to earnings ratio of Clearmind Medicine Inc. – LS:A41YK5 - TradingView — Track All Markets
Clearmind Medicine Inc. Revenue Breakdown – LS:A41YK5 - TradingView — Track All Markets
Basic earnings per share (basic EPS) of Clearmind Medicine Inc. – LS:A41YK5 - TradingView — Track All Markets
Book value per share of Clearmind Medicine Inc. – BER:CWY - TradingView — Track All Markets
Net margin % of Clearmind Medicine Inc. – FWB:CWY - TradingView — Track All Markets
0.93%
자본화:
|
볼륨(24시간):